The company witnessed a 5.75% growth in the revenue at Rs. 13450.90 millions for the quarter ended September 2019 as compared to Rs. 12719.90 millions during the year-ago period.A comparatively good net profit growth of 25.34% to Rs. 3453.10 millions was reported for the quarter ended September 2019 compared to Rs. 2754.90 millions of previous same quarter.Operating profit surged to 4739.40 millions from the corresponding previous quarter of 4426.80 millions. (Rs. in Million) Quarter ended Year to Date Year ended 201909 201809 % Var 201909 201809 % Var 201903 201803 % Var Sales 13450.90 12719.90 5.75 25394.10 23791.30 6.74 47820.10 43770.50 9.25 Other Income 781.30 890.10 -12.22 2047.10 1854.60 10.38 4326.00 2574.10 68.06 PBIDT 4739.40 4426.80 7.06 8809.20 7694.20 14.49 15735.70 11407.60 37.94 Interest 17.80 1.90 836.84 34.80 3.70 840.54 7.80 20.30 -61.58 PBDT 4721.60 4424.90 6.71 8774.40 7690.50 14.09 15727.90 11387.30 38.12 Depreciation 203.30 150.70 34.90 399.50 297.70 34.20 605.00 643.70 -6.01 PBT 4518.30 4274.20 5.71 8374.90 7392.80 13.28 15122.90 10743.60 40.76 TAX 1065.20 1519.30 -29.89 2441.00 2633.50 -7.31 5294.90 3742.60 41.48 Deferred Tax 323.00 9.60 3264.58 341.20 -14.50 -2453.10 15.60 123.50 -87.37 PAT 3453.10 2754.90 25.34 5933.90 4759.30 24.68 9828.00 7001.00 40.38 Equity 420.60 420.60 0.00 420.60 420.60 0.00 420.60 420.60 0.00 PBIDTM(%) 35.23 34.80 1.24 34.69 32.34 7.26 32.91 26.06 26.26

Glaxosmithkline Consumer Healthcare is currently trading at Rs. 7415.00, up by 34.35 points or 0.47% from its previous closing of Rs. 7379.40 on the BSE.The scrip opened at Rs. 7425.00 and has touched a high and low of Rs. 7480.00 and Rs. 7347.00 respectively. The BSE group `A` stock of face value Rs. 10 has touched a 52 week high of Rs. 7934.85 on 18-Dec-2018 and a 52 week low of Rs. 6340.00 on 08-Oct-2018.Last one week high and low of the scrip stood at Rs. 7489.20 and Rs. 7235.00 respectively. The current market cap of the company is Rs. 31263.88 crore.The promoters holding in the company stood at 72.46%, while Institutions and Non-Institutions held 11.12% and 16.42% respectively.Glaxosmithkline Consumer Healthcare has reported 23.77% rise in its net profit at Rs 248.08 crore for the quarter ended June 30, 2019 as compared to Rs 200.44 crore for the same quarter in the previous year. Total income of the company increased by 9.75% at Rs 1,320.90 crore for Q1FY20 as compared Rs 1,203.59 crore for the corresponding quarter previous year.Glaxosmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks.

Glaxosmithkline Consumer Healthcare is currently trading at Rs. 7486.95, up by 75.15 points or 1.01% from its previous closing of Rs. 7411.80 on the BSE.The scrip opened at Rs. 7494.45 and has touched a high and low of Rs. 7545.50 and Rs. 7460.00 respectively. So far 278 shares were traded on the counter.The BSE group `A` stock of face value Rs. 10 has touched a 52 week high of Rs. 7934.85 on 18-Dec-2018 and a 52 week low of Rs. 5985.00 on 25-Jun-2018.Last one week high and low of the scrip stood at Rs. 7545.50 and Rs. 7250.00 respectively. The current market cap of the company is Rs. 31486.77 crore.The promoters holding in the company stood at 72.46%, while Institutions and Non-Institutions held 11.49% and 16.05% respectively.Glaxosmithkline Consumer Healthcare has received approval from its shareholders for merger with Hindustan Unilever (HUL). The company has received 99.99 percent votes in favour of the scheme of amalgamation among the company and HUL in the National Company Law Tribunal-convened meeting of the equity shareholders on June 1, 2019.Glaxosmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks.

Glaxosmithkline Consumer Healthcare is currently trading at Rs. 7130.00, up by 94.15 points or 1.34% from its previous closing of Rs. 7035.85 on the BSE.The scrip opened at Rs. 7144.00 and has touched a high and low of Rs. 7165.60 and Rs. 7100.00 respectively. The BSE group `A` stock of face value Rs. 10 has touched a 52 week high of Rs. 7934.85 on 18-Dec-2018 and a 52 week low of Rs. 5850.00 on 14-May-2018.Last one week high and low of the scrip stood at Rs. 7165.60 and Rs. 6905.00 respectively. The current market cap of the company is Rs. 30048.68 crore.The promoters holding in the company stood at 72.46%, while Institutions and Non-Institutions held 11.49% and 16.05% respectively.Glaxosmithkline Consumer Healthcare has reported a rise of 34.94% in its net profit at Rs 285.81 crore for the quarter under review as compared to Rs 211.81 crore for the same quarter in the previous year. Total income of the company increased by 11.49% at Rs 1408.95 crore for Q4FY19 as compared Rs 1,263.75 crore for the corresponding quarter previous year.For the year ended March 31, 2019, the company has reported a rise of 40.38% in its net profit at Rs 982.80 crore as compared to Rs 700.10 crore for the previous year. Total income of the company increased by 12.52% at Rs 5214.61 crore for year under review as compared to Rs 4634.46 crore for year ended March 31, 2018.

The March 2019 quarter revenue stood at Rs. 12860.60 millions, up 9.03% as compared to Rs. 11795.80 millions during the corresponding quarter last year.A good growth in profit of 34.94% reported to Rs. 2858.10  millions over Rs. 2118.10 millions of corresponding previous quarter.Operating Profit saw a handsome growth to 4413.70 millions from 3342.00 millions in the quarter ended March 2019. (Rs. in Million) Quarter ended Year to Date Year ended 201903 201803 % Var 201903 201803 % Var 201903 201803 % Var Sales 12860.60 11795.80 9.03 47820.10 43770.50 9.25 47820.10 43770.50 9.25 Other Income 1228.90 841.70 46.00 4326.00 2574.10 68.06 4326.00 2574.10 68.06 PBIDT 4413.70 3342.00 32.07 15735.70 11407.60 37.94 15735.70 11407.60 37.94 Interest 2.00 7.70 -74.03 7.80 20.30 -61.58 7.80 20.30 -61.58 PBDT 4411.70 3334.30 32.31 15727.90 11387.30 38.12 15727.90 11387.30 38.12 Depreciation 149.20 145.40 2.61 605.00 643.70 -6.01 605.00 643.70 -6.01 PBT 4262.50 3188.90 33.67 15122.90 10743.60 40.76 15122.90 10743.60 40.76 TAX 1404.40 1070.80 31.15 5294.90 3742.60 41.48 5294.90 3742.60 41.48 Deferred Tax 12.80 28.30 -54.77 15.60 123.50 -87.37 15.60 123.50 -87.37 PAT 2858.10 2118.10 34.94 9828.00 7001.00 40.38 9828.00 7001.00 40.38 Equity 420.60 420.60 0.00 420.60 420.60 0.00 420.60 420.60 0.00 PBIDTM(%) 34.32 28.33 21.13 32.91 26.06 26.26 32.91 26.06 26.26

Glaxosmithkline Consumer Healthcare is currently trading at Rs. 7300.00, up by 14.90 points or 0.20% from its previous closing of Rs. 7285.10 on the BSE.The scrip opened at Rs. 7315.00 and has touched a high and low of Rs. 7319.55 and Rs. 7251.00 respectively. So far 123 shares were traded on the counter.The BSE group `A` stock of face value Rs. 10 has touched a 52 week high of Rs. 7934.85 on 18-Dec-2018 and a 52 week low of Rs. 5725.00 on 02-Apr-2018.Last one week high and low of the scrip stood at Rs. 7329.00 and Rs. 7172.00 respectively. The current market cap of the company is Rs. 30629.05 crore.The promoters holding in the company stood at 72.46%, while Institutions and Non-Institutions held 12.01% and 15.54% respectively.GlaxoSmithKline Consumer Healthcare has received an approval from the Competition Commission of India (CCI) for its merger deal with Hindustan Unilever (HUL).The scheme remains subject to the receipt of other necessary statutory and regulatory approvals under applicable laws, including by the NSE, SSE, SEBI, NCLT and the respective shareholders and creditors of HUL and the company.Glaxosmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks.

Glaxosmithkline Consumer Healthcare is currently trading at Rs. 5407.00, up by 6.60 points or 0.12% from its previous closing of Rs. 5400.40 on the BSE.The scrip opened at Rs. 5439.95 and has touched a high and low of Rs. 5440.00 and Rs. 5400.00 respectively. So far 376 shares were traded on the counter.The BSE group `A` stock of face value Rs. 10 has touched a 52 week high of Rs. 6488.00 on 12-Aug-2016 and a 52 week low of Rs. 4650.00 on 15-Nov-2016.Last one week high and low of the scrip stood at Rs. 5575.00 and Rs. 5365.00 respectively. The current market cap of the company is Rs. 22709.99 crore.The promoters holding in the company stood at 72.46%, while institutions and non-institutions held 12.79% and 14.75% respectively.GlaxoSmithkline Consumer Healthcare has reported a fall of 17.67% in its net profit at Rs 132.23 crore for the quarter ended June 30, 2017, as compared to Rs 160.61 crore for the same quarter in the previous year. Total income of the company decreased by 1.52% at Rs 1101.57 crore for Q1FY18 as compared Rs 1118.56 crore for the corresponding quarter previous year.GlaxoSmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks. It exports products to countries like Bangladesh, Myanmar, Sri Lanka, Middle East, Fiji, Mauritius, Nepal, Bhutan and many more.

GlaxoSmithkline Consumer Healthcare is currently trading at Rs. 5410.00, down by 95.30 points or 1.73% from its previous closing of Rs. 5505.30 on the BSE.The scrip opened at Rs. 5435.00 and has touched a high and low of Rs. 5455.55 and Rs. 5387.00 respectively. The BSE group `A` stock of face value Rs. 10 has touched a 52 week high of Rs. 6488.00 on 12-Aug-2016 and a 52 week low of Rs. 4650.00 on 15-Nov-2016.Last one week high and low of the scrip stood at Rs. 5575.00 and Rs. 5365.00 respectively. The current market cap of the company is Rs. 22,752.00 crore.The promoters holding in the company stood at 72.46%, while Institutions and Non-Institutions held 12.79% and 14.75% respectively.The company has reported a fall of 17.67% in its net profit at Rs 132.23 crore for first quarter ended June 30, 2017 as compared to Rs 160.61 crore for the same quarter in the previous year. Total income of the company decreased by 1.52% at Rs 1101.57 crore for Q1FY18 as compared Rs 1118.56 crore for the corresponding quarter previous year.GlaxoSmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks. It exports products to countries like Bangladesh, Myanmar, Sri Lanka, Middle East, Fiji, Mauritius, Nepal, Bhutan and many more.

GlaxoSmithkline Consumer Healthcare is currently trading at Rs. 5032.00, down by 85.90 points or 1.68% from its previous closing of Rs. 5117.90 on the BSE.The scrip opened at Rs. 5117.00 and has touched a high and low of Rs. 5143.90 and Rs. 5024.00 respectively. The BSE group `A` stock of face value Rs. 10 has touched a 52 week high of Rs. 6584.20 on 25-Jul-2016 and a 52 week low of Rs. 4650.00 on 15-Nov-2016.Last one week high and low of the scrip stood at Rs. 5150.30 and Rs. 5024.00 respectively. The current market cap of the company is Rs. 21,162.35 crore.The promoters holding in the company stood at 72.46%, while Institutions and Non-Institutions held 12.77% and 14.77% respectively.The company has reported 8.25% fall in its net profit at Rs 136.41 crore for third quarter ended December 31, 2016 as compared to Rs 148.68 crore for the same quarter in the previous year. Total income of the company decreased by 11.94% at Rs 1016.09 crore for the quarter under review as compared Rs 1153.86 crore for the corresponding quarter previous year.GlaxoSmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks. It exports products to countries like Bangladesh, Myanmar, Sri Lanka, Middle East, Fiji, Mauritius, Nepal, Bhutan and many more.

GlaxoSmithkline Consumer Healthcare has informed that at the 57th Annual General Meeting of the Company held on August 5, 2016 at 9.00 a.m. at Punjab Public School Auditorium, The Punjab Public School (Senior Wing), Nabha 147 201 (Punjab), the Chairman ordered voting through Ballot Paper on all the resolutions mentioned in the Notice of the Annual General Meeting. The details of the voting results of the voting through Ballot Paper at the Annual General Meeting and the remote electronic voting on all the resolutions contained in the Notice shall be forwarded on receipt of the report of the scrutinizers.The above information is a part of company’s filings submitted to BSE.

GlaxoSmithkline Consumer Healthcare has informed that in accordance with the Company’s Policy on Insider Trading, the date of commencement of closing of ‘Trading Window’ shall be from June 24, 2016 and shall end 24 hours after declaration of Audited / Unaudited Financial Results for the Quarter ending June 30, 2016.The above information is a part of company’s filings submitted to BSE.

GlaxoSmithKline Consumer Healthcare (GSK Consumer ) is currently trading at Rs. 5,610.00, up by 22.45 points or 0.40% from its previous closing of Rs. 5587.55 on the BSE.The scrip opened at Rs. 5620.00 and has touched a high and low of Rs. 5642.45 and Rs. 5596.20 respectively. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 6800.00 on 23-Dec-2015 and a 52 week low of Rs. 5366.50 on 02-Mar-2016.Last one week high and low of the scrip stood at Rs. 5686.30 and Rs. 5567.90 respectively. The current market cap of the company is Rs. 23,593.00 crore.The promoters holding in the company stood at 72.46%, while Institutions and Non-Institutions held 12.72% and 14.83% respectively. GlaxoSmithKline Consumer Healthcare has resumed operations with effect from June 15, 2016 at its manufacturing facility at Nabha in Punjab following a wage settlement agreement with its striking workers. The company had suspended operations temporarily at factory from May 21 following disruptions by its workforce who were demanding hike in wages.GlaxoSmithKline Consumer Healthcare is a subsidiary of GlaxoSmithKline plc of UK. GlaxoSmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks. It exports products to countries like Bangladesh, Myanmar, Sri Lanka, Middle East, Fiji, Mauritius, Nepal, Bhutan and many more.